Skip to main content

Clinical Trials Search at Vanderbilt-Ingram Cancer Center



A Phase Ib Open Label Study to assess the Safety and Pharmacokinetics of NUC-3373, a Nucleotide Analogue, given in Combination with Standard Agents used in Colorectal Cancer Treatment

Multiple Cancer Types

Colon, Phase I, Rectal
I
Ciombor, Kristen
NCT03428958
VICCGIP1851

To learn more about any of our clinical
trials, call 615-936-8422.